MedPath

Xylometazoline

Generic Name
Xylometazoline
Drug Type
Small Molecule
Chemical Formula
C16H24N2
CAS Number
526-36-3
Unique Ingredient Identifier
WPY40FTH8K

Overview

Xylometazoline is an imidazoline derivative with sympathomimetic and nasal decongestant activity. Xylometazoline works by binding to alpha (α)-adrenergic receptors to cause vasoconstriction of nasal blood vessels. Xylometazoline is available in over-the-counter (OTC) nasal sprays or drops to temporarily relieve nasal congestion due to cold, hay fever or other respiratory allergies. In some countries, it is available as combination products with ipratropium, domiphen, or dexpanthenol.

Background

Xylometazoline is an imidazoline derivative with sympathomimetic and nasal decongestant activity. Xylometazoline works by binding to alpha (α)-adrenergic receptors to cause vasoconstriction of nasal blood vessels. Xylometazoline is available in over-the-counter (OTC) nasal sprays or drops to temporarily relieve nasal congestion due to cold, hay fever or other respiratory allergies. In some countries, it is available as combination products with ipratropium, domiphen, or dexpanthenol.

Indication

Xylometazoline is indicated for the temporary relief of nasal congestion due to cold, hay fever or other respiratory allergies.

Associated Conditions

  • Allergic Rhinitis (AR)
  • Nasal Congestion
  • Seasonal Allergic Rhinitis

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

SNUP STADA® SPRAY 0.1%
Manufacturer:Ursapharm Arzneimittel GmbH
Form:SPRAY
Strength:0.100g
Online:Yes
Approved: 2017/03/23
Approval:SIN15198P
OTRIVIN NASAL SPRAY 0.1%
Manufacturer:GSK Consumer Healthcare SARL
Form:SPRAY
Strength:1 mg/ml
Online:Yes
Approved: 2001/08/14
Approval:SIN11624P
OTRIVIN NASAL DROPS 0.05%
Manufacturer:GSK Consumer Health SARL
Form:SOLUTION
Strength:0.5 mg/ml
Online:Yes
Approved: 2001/08/14
Approval:SIN11622P

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath